Evidence map›Paper›PMID 42222709›Full record

ArticlePrecision chemistry2026

Atomically Precise Polyanionic Boron Cluster Agents with Broad-Spectrum Antiviral Activity.

Yueying Wang, Balamurugan Arumugam, Evan Doud, David DeLuca, Michael Rebelo, Otto O Yang, Alexander M Spokoyny

Abstract read
In one paragraph

Article in Precision chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yueying WangDepartment of Chemistry and Biochemistry, University of California, Los Angeles, 607 Charles E. Young Drive East, Los Angeles, California 90095, United States.ORCID https://orcid.org/0000-0002-4204-0065
Balamurugan ArumugamDivision of Infectious Diseases, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, 10833 Le Conte Ave, Los Angeles, California 90095, United States.
Evan DoudDepartment of Chemistry and Biochemistry, University of California, Los Angeles, 607 Charles E. Young Drive East, Los Angeles, California 90095, United States.
David DeLucaDepartment of Chemistry and Biochemistry, University of California, Los Angeles, 607 Charles E. Young Drive East, Los Angeles, California 90095, United States.
Michael RebeloDepartment of Chemistry and Biochemistry, University of California, Los Angeles, 607 Charles E. Young Drive East, Los Angeles, California 90095, United States.
Otto O YangDivision of Infectious Diseases, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, 10833 Le Conte Ave, Los Angeles, California 90095, United States.ORCID https://orcid.org/0000-0003-1970-8992
Alexander M SpokoynyDepartment of Chemistry and Biochemistry, University of California, Los Angeles, 607 Charles E. Young Drive East, Los Angeles, California 90095, United States.ORCID https://orcid.org/0000-0002-5683-6240

Funding

Inorganic Chemistry Tools for Bioconjugation, Recognition and ImagingR35GM124746 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Alexander Michael Spokoyny · 2017 to 2026
$4.0M
NIGMS NIH HHS R35 GM124746
6 · The paper itself

Abstract

The development of antivirals capable of addressing infections from multiple viruses is critically needed, as underscored by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic and ongoing annual influenza epidemics. Polyanionic polymer and hybrid gold nanoparticle (AuNP) systems have both previously shown significant infection inhibition activity against a wide variety of enveloped viruses. However, both of these systems exhibit variability in molecular weight and charge density distribution, which makes detailed structure-activity relationships difficult to ascertain. In this work, we report the synthesis of well-defined, dodecaborate-based clusters that are densely surface functionalized with charged ligands. These compounds exhibit minimal cytotoxic effects against mammalian cells, and several structures possess promising antiviral activity against both human immunodeficiency virus (HIV-1) and cytomegalovirus (CMV). This library of compounds offers a promising scaffold from which the roles of ligand identity, molecule size, and charge density on antiviral activity can be further studied and may ultimately help guide future design of antiviral agents.

Indexed as

antiviral activityCMVdodecaborate clustersfunctionalization chemistryHIV-1

Identifiers

PMID42222709
PMCPMC13217325

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.